
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1085 | 954 | 1085 | 825 | 1120 | - |
Fund Return | 8.52% | -4.6% | 8.52% | -6.2% | 2.3% | - |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UBAM Swiss Eq UD CHF | 1.86B | 9.15 | -5.80 | - | ||
UBAM Swiss Eq RC CHF | 1.86B | 7.17 | -1.69 | 5.55 | ||
UBAM Swiss Eq AHC CHF | 1.86B | 8.51 | -6.20 | - | ||
UBAM Swiss Eq IHC CHF | 1.86B | 8.95 | -5.83 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Invesco JapEqAdvantage A CHF H Acc | 66.08B | 1.96 | 11.03 | 7.29 | ||
Cap Group NewPerspective lux Bh CHF | 16.87B | 3.98 | 3.30 | - | ||
Cap Group NewPerspective lux Zh CHF | 16.87B | 4.03 | 4.08 | - | ||
CapGroup NewPerspective lux ZLh CHF | 16.87B | 15.32 | 0.16 | - | ||
LU1201780084 | 26.66M | 3.81 | 6.65 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novartis | CH0012005267 | 7.33 | 98.15 | +1.54% | |
ABB | CH0012221716 | 6.94 | 52.26 | -0.19% | |
Roche Holding Participation | CH0012032048 | 6.61 | 298.40 | +1.05% | |
Nestle | CH0038863350 | 6.26 | 85.10 | +3.35% | |
UBS Group | CH0244767585 | 6.08 | 30.32 | +0.83% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review